Chassis Organism Engineering Patents: Who Leads, Gaps 2026
Chassis organism engineering patents: mapping the claim territory around genome reduction and host tractability
80.8% concentration. The top 5 of 49 ranked assignees hold 101 of the 125 records in scope — this field is claimed by a small group, not a broad field of entrants. Filings peaked at 15 in 2017. The comparable, complete span from 2021 (5) to 2024 (1) shows an -80% decline; 2025 and 2026 figures are still filling in under the publication lag and should not be read as a continuation of that slope.
- 1WISCONSIN ALUMNI RES FOUND46
- 2UNIV OF FLORIDA RESEARCH FOUNDATION INC19
- 3EVOLVA SA(CH)16
- 4SYNTHETIC GENOMICS INC15
- 5J CRAIG VENTER INSTITUTE INC5
See the full chassis organism engineering analysis in Eureka
- The complete ranking, not just the top five
- Every IPC branch with its share of the corpus
- The most-cited records, and where claim space is still thin
Common questions on chassis organism engineering patents
Who holds the most patents in chassis organism engineering?
One assignee leads the ranked field with 46 of the 125 records in scope, well ahead of the fifth-ranked assignee at 5 records. The top 5 of 49 ranked assignees together hold 80.8% of all records, so the field is concentrated at the top rather than spread evenly. Anyone assessing freedom-to-operate should start with that leading portfolio before looking at the long tail of single-filing entrants.
Is chassis organism engineering patent filing growing or declining?
Filing peaked in 2017 at 15 records and has declined since; the most recent complete comparison, 2021 (5) to 2024 (1), shows an -80% drop. Figures for 2025 and 2026 are still incomplete because publication typically lags filing by around 18 months, so it would be premature to call the field dead based on those years alone. The safest reading is that filing activity has genuinely cooled through 2024, with the very latest trend still unresolved.
What technology areas dominate chassis organism engineering patents?
Nearly all records, 93.6% of the 125 in scope, carry the C12N classification covering microorganisms and genetic engineering, which is expected given the search terms. Fermentation and enzymatic synthesis (C12P) appears in 40.8% of records and microorganism indexing (C12R) in 36.0%, showing that most chassis claims are paired with a specific production or classification use rather than filed as standalone host claims. Smaller classes like bioinformatics (G16B, 8.8%) and combinatorial libraries (C40B, 4.8%) mark narrower, less-crowded branches.
Disclaimer. This analysis is based on Patsnap Eureka data drawn from a limited snapshot of global patent records and is provided for general information and reference only. Patent data carries inherent limitations — recent filings are under-counted because of publication lag, counts may be on a record or family basis, classification and applicant-name data may contain errors or duplicates, and the underlying search query defines the scope shown — so the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing here is an exhaustive prior-art, novelty, freedom-to-operate or validity search, nor does it constitute legal, financial or professional advice, and it should not be relied upon as such. Verify independently and review with qualified patent and legal professionals before acting on it.
Method: Filing trend and technology composition. Derived from a Patsnap search on Chassis Organism Engineering covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish. Every share divides by all records in scope. Data: Patsnap Eureka. See the full landscape report.